carbamazepine has been researched along with Cacosmia in 1 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carbamazepine was administered for 11 weeks." | 1.72 | Post-COVID-19 olfactory dysfunction: carbamazepine as a treatment option in a series of cases. ( Alvarenga, RMP; Alves, MCDF; Gouvea, EG; Hammerle, MB; Pereira, TV; Pinheiro, PG; Pires, KL; Rueda Lopes, FC; Sales, DS; Schmidt, SL; Vasconcelos, CCF, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vasconcelos, CCF | 1 |
| Hammerle, MB | 1 |
| Sales, DS | 1 |
| Rueda Lopes, FC | 1 |
| Pinheiro, PG | 1 |
| Gouvea, EG | 1 |
| Alves, MCDF | 1 |
| Pereira, TV | 1 |
| Schmidt, SL | 1 |
| Alvarenga, RMP | 1 |
| Pires, KL | 1 |
1 other study available for carbamazepine and Cacosmia
| Article | Year |
|---|---|
Post-COVID-19 olfactory dysfunction: carbamazepine as a treatment option in a series of cases.
Topics: Carbamazepine; COVID-19; COVID-19 Drug Treatment; Humans; Olfaction Disorders; SARS-CoV-2; Smell | 2022 |